Bottom line
GGHCX vs SCHLX: the short answer
GGHCX (INVESCO Health Care Fund) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 51% by weight.
SCHLX is cheaper at 1.06% vs 1.07% — a difference of $1.00 a year per $10,000 invested.
GGHCX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
GGHCX vs SCHLX side by side
| GGHCX | SCHLX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Invesco | DWS (Xtrackers) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.07% | 1.06% |
| Annual cost per $10k | $107 | $106 |
| 10-yr cost on $10k (prospectus) | $1,784 | $1,294 |
| Max front load | 5.5% | 0% |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +9.2% | — |
| 5-yr return (annualized) | +2.6% | — |
| 10-yr return (annualized) | +5.8% | — |
| Best quarter | +19.6% | — |
| Worst quarter | −16.5% | — |
| Net assets (fund) | $1.2B | $231.8M |
| Number of holdings | 82 | 65 |
| Portfolio turnover | 59% | 2% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
9 of GGHCX's top 25 holdings also appear in SCHLX's top 25.
| Holding | GGHCX | SCHLX |
|---|---|---|
| Eli Lilly and Co. | 10.59% | 13.85% |
| Johnson & Johnson | 6.76% | 6.19% |
| UnitedHealth Group Inc. | 6.17% | 5.73% |
| Merck & Co., Inc. | 4.59% | 4.85% |
| AbbVie Inc. | 4.03% | 4.90% |
| Gilead Sciences, Inc. | 3.63% | 2.78% |
| Cardinal Health, Inc. | 2.10% | 1.34% |
| Vertex Pharmaceuticals Inc. | 2.01% | 2.45% |
| Thermo Fisher Scientific Inc. | 1.55% | 3.46% |
Source: SEC Form N-PORT
GGHCX top 10
- Eli Lilly and Co. — 10.59%
- Johnson & Johnson — 6.76%
- UnitedHealth Group Inc. — 6.17%
- Invesco Private Prime Fund — 4.67%
- Merck & Co., Inc. — 4.59%
- AbbVie Inc. — 4.03%
- Gilead Sciences, Inc. — 3.63%
- argenx SE — 3.24%
- CVS Health Corp. — 2.52%
- Welltower Inc. — 2.34%
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
FAQ
What is the difference between GGHCX and SCHLX?
GGHCX (INVESCO Health Care Fund) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 51% by weight. SCHLX is cheaper at 1.06% vs 1.07% — a difference of $1.00 a year per $10,000 invested.
Which is cheaper, GGHCX or SCHLX?
SCHLX has the lower expense ratio (1.06%).
Should I own both GGHCX and SCHLX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.